The Supreme Court of India has questioned the government's handling of medicine pricing during a recent hearing, highlighting significant discrepancies between maximum retail prices and prices to retailers.
Justices criticized the government for allowing exorbitant markups on drugs and emphasized the need for a pricing system that prioritizes patient welfare over commercial interests.
The court reserved its judgment on petitions calling for stricter price controls and accountability within the pharmaceutical sector.
